Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 5G3 TalkMed > Company Executives
5G3 TalkMed
0.3800.0000.00%
NamePositionSalaryService DateEducationAgeGenderUpdated
Dr. Peng Tiam AngExecutive Director and Chief Executive Officer----------04/04/2022
Dr. Kei Siong KhooExecutive Director and Chief Operating Officer----------04/04/2022
Boon Yong LeeChief Financial Officer and Joint Company Secretary----------04/04/2022
Heng Chong Benny LimJoint Company Secretary----------04/04/2022
Anne Low JacquelineJoint Company Secretary----------04/04/2022
Su Xian ChinJoint Company Secretary----------04/09/2019
S. Chandra DasNon-Executive Independent Chairman of the Board----------04/04/2022
Jen Howe LimNon-Executive Director----------04/04/2022
Teong Jin George LimNon-Executive Director----------04/04/2022
Ching Ching LeongNon-Executive Director----------04/04/2022
Yih Pin SitohIndependent Director----------04/04/2022
Yock Hian DanIndependent Director----------04/04/2022
Company Overview More
TalkMed Group Ltd operates as an investment holding company. The principal activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into three reportable operating segments, Oncology Services, Stem Cells Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, Hong Kong and Vietnam of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.
CEO: --
Market: --
Watchlist